Supplementary Tables S2-13 from Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor–Positive Breast Cancer

Supplementary Tables S2-13 from Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor–Positive Breast Cancer

<p>Supplementary Tables S2-13</p>

Spremljeno u:

Bibliografski detalji
Glavni autor:	Francisco Hermida-Prado (14958909) (author)
Daljnji autori:	Yingtian Xie (14958900) (author), Shira Sherman (17078923) (author), Zsuzsanna Nagy (14958888) (author), Douglas Russo (15051419) (author), Tara Akhshi (17078926) (author), Zhengtao Chu (17078929) (author), Avery Feit (14958894) (author), Marco Campisi (14960085) (author), Minyue Chen (15132641) (author), Agostina Nardone (14958879) (author), Cristina Guarducci (14958906) (author), Klothilda Lim (14958912) (author), Alba Font-Tello (14958903) (author), Irene Lee (17078932) (author), Juana García-Pedrero (17078935) (author), Israel Cañadas (15116782) (author), Judith Agudo (17078938) (author), Ying Huang (17078941) (author), Tal Sella (15907645) (author), Qingchun Jin (17078944) (author), Nabihah Tayob (15029789) (author), Elizabeth A. Mittendorf (15454561) (author), Sara M. Tolaney (15051440) (author), Xintao Qiu (14958882) (author), Henry Long (14958854) (author), William F. Symmans (15056362) (author), Jia-Ren Lin (15033015) (author), Sandro Santagata (14941840) (author), Isabelle Bedrosian (15043389) (author), Denise A. Yardley (17078947) (author), Ingrid A. Mayer (16617143) (author), Edward T. Richardson (17078950) (author), Giacomo Oliveira (17078953) (author), Catherine J. Wu (14944480) (author), Eugene F. Schuster (17078956) (author), Mitch Dowsett (15046881) (author), Alana L. Welm (11627892) (author), David Barbie (17078959) (author), Otto Metzger (17078962) (author), Rinath Jeselsohn (14948026) (author)
Izdano:	2025
Teme:	Cancer Tumor Biology Immuno-oncology Breast Cancer Immunotherapy Tumor Microenvironment Immune cells and the microenvironment
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!

Slični predmeti

Supplementary Table S13 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic ceRNA Network Related to Immune Infiltration in Sarcoma
od: Dongliang Leng (17079663)
Izdano: (2025)

Inhibition of Polo-like kinase 1 (PLK1) synergizes with Vemurafenib in the treatment of melanoma.
od: Fengyi Mao (15073242)
Izdano: (2025)

Additional file 13 of Development of a cancer metastasis-associated risk model via multi-machine-learning algorithms for prognostic risk evaluation and clinical application in oral squamous cell carcinoma
od: Xu Han (141301)
Izdano: (2025)

Supplementary Table S1 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic ceRNA Network Related to Immune Infiltration in Sarcoma
od: Dongliang Leng (17079663)
Izdano: (2025)

Supplementary Table S10 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic ceRNA Network Related to Immune Infiltration in Sarcoma
od: Dongliang Leng (17079663)
Izdano: (2025)

Supplementary Table S11 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic ceRNA Network Related to Immune Infiltration in Sarcoma
od: Dongliang Leng (17079663)
Izdano: (2025)

Supplementary Table S12 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic ceRNA Network Related to Immune Infiltration in Sarcoma
od: Dongliang Leng (17079663)
Izdano: (2025)

Supplementary Table S14 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic ceRNA Network Related to Immune Infiltration in Sarcoma
od: Dongliang Leng (17079663)
Izdano: (2025)

Supplementary Table S15 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic ceRNA Network Related to Immune Infiltration in Sarcoma
od: Dongliang Leng (17079663)
Izdano: (2025)

Supplementary Table S16 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic ceRNA Network Related to Immune Infiltration in Sarcoma
od: Dongliang Leng (17079663)
Izdano: (2025)

Supplementary Table S17 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic ceRNA Network Related to Immune Infiltration in Sarcoma
od: Dongliang Leng (17079663)
Izdano: (2025)

Supplementary Table S2 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic ceRNA Network Related to Immune Infiltration in Sarcoma
od: Dongliang Leng (17079663)
Izdano: (2025)

Supplementary Table S3 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic ceRNA Network Related to Immune Infiltration in Sarcoma
od: Dongliang Leng (17079663)
Izdano: (2025)

Supplementary Table S4 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic ceRNA Network Related to Immune Infiltration in Sarcoma
od: Dongliang Leng (17079663)
Izdano: (2025)

Supplementary Table S5 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic ceRNA Network Related to Immune Infiltration in Sarcoma
od: Dongliang Leng (17079663)
Izdano: (2025)

Supplementary Table S6 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic ceRNA Network Related to Immune Infiltration in Sarcoma
od: Dongliang Leng (17079663)
Izdano: (2025)

Supplementary Table S7 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic ceRNA Network Related to Immune Infiltration in Sarcoma
od: Dongliang Leng (17079663)
Izdano: (2025)

Supplementary Table S8 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic ceRNA Network Related to Immune Infiltration in Sarcoma
od: Dongliang Leng (17079663)
Izdano: (2025)

Supplementary Table S9 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic ceRNA Network Related to Immune Infiltration in Sarcoma
od: Dongliang Leng (17079663)
Izdano: (2025)

Table S1 from Elevated Mast Cell Abundance Is Associated with Enrichment of CCR2<sup>+</sup> Cytotoxic T Cells and Favorable Prognosis in Lung Adenocarcinoma
od: Fanfan Fan (16799646)
Izdano: (2025)

Table S2 from Elevated Mast Cell Abundance Is Associated with Enrichment of CCR2<sup>+</sup> Cytotoxic T Cells and Favorable Prognosis in Lung Adenocarcinoma
od: Fanfan Fan (16799646)
Izdano: (2025)

Table S3 from Elevated Mast Cell Abundance Is Associated with Enrichment of CCR2<sup>+</sup> Cytotoxic T Cells and Favorable Prognosis in Lung Adenocarcinoma
od: Fanfan Fan (16799646)
Izdano: (2025)

Table S4 from Elevated Mast Cell Abundance Is Associated with Enrichment of CCR2<sup>+</sup> Cytotoxic T Cells and Favorable Prognosis in Lung Adenocarcinoma
od: Fanfan Fan (16799646)
Izdano: (2025)

Table S5 from Elevated Mast Cell Abundance Is Associated with Enrichment of CCR2<sup>+</sup> Cytotoxic T Cells and Favorable Prognosis in Lung Adenocarcinoma
od: Fanfan Fan (16799646)
Izdano: (2025)

Table S6 from Elevated Mast Cell Abundance Is Associated with Enrichment of CCR2<sup>+</sup> Cytotoxic T Cells and Favorable Prognosis in Lung Adenocarcinoma
od: Fanfan Fan (16799646)
Izdano: (2025)

Table S7 from Elevated Mast Cell Abundance Is Associated with Enrichment of CCR2<sup>+</sup> Cytotoxic T Cells and Favorable Prognosis in Lung Adenocarcinoma
od: Fanfan Fan (16799646)
Izdano: (2025)

Supp. Figure 1 from Parkin Deficiency Suppresses Antigen Presentation to Promote Tumor Immune Evasion and Immunotherapy Resistance
od: Renzo Perales-Linares (17314863)
Izdano: (2025)

Supp. Figure 2 from Parkin Deficiency Suppresses Antigen Presentation to Promote Tumor Immune Evasion and Immunotherapy Resistance
od: Renzo Perales-Linares (17314863)
Izdano: (2025)

Supp. Figure 3 from Parkin Deficiency Suppresses Antigen Presentation to Promote Tumor Immune Evasion and Immunotherapy Resistance
od: Renzo Perales-Linares (17314863)
Izdano: (2025)

Supp. Figure 4 from Parkin Deficiency Suppresses Antigen Presentation to Promote Tumor Immune Evasion and Immunotherapy Resistance
od: Renzo Perales-Linares (17314863)
Izdano: (2025)

Supp. Figure 5 from Parkin Deficiency Suppresses Antigen Presentation to Promote Tumor Immune Evasion and Immunotherapy Resistance
od: Renzo Perales-Linares (17314863)
Izdano: (2025)

Supp. Figure 6 from Parkin Deficiency Suppresses Antigen Presentation to Promote Tumor Immune Evasion and Immunotherapy Resistance
od: Renzo Perales-Linares (17314863)
Izdano: (2025)

Supplementary Data S1 from Genomic Complexity Predicts Resistance to Endocrine Therapy and CDK4/6 Inhibition in Hormone Receptor–Positive (HR+)/HER2-Negative Metastatic Breast Cancer
od: Andrew A. Davis (15030032)
Izdano: (2025)

Supplementary video from Phagocytosis of Glioma Cells Enhances the Immunosuppressive Phenotype of Bone Marrow–Derived Macrophages
od: Min Wu (14962986)
Izdano: (2025)

Table S1 from Phagocytosis of Glioma Cells Enhances the Immunosuppressive Phenotype of Bone Marrow–Derived Macrophages
od: Min Wu (14962986)
Izdano: (2025)

Table S2 from Phagocytosis of Glioma Cells Enhances the Immunosuppressive Phenotype of Bone Marrow–Derived Macrophages
od: Min Wu (14962986)
Izdano: (2025)

Table S3 from Phagocytosis of Glioma Cells Enhances the Immunosuppressive Phenotype of Bone Marrow–Derived Macrophages
od: Min Wu (14962986)
Izdano: (2025)

Suppl video 1 from Neutrophil Conversion to a Tumor-Killing Phenotype Underpins Effective Microbial Therapy
od: Andrew O. Yam (15293045)
Izdano: (2025)

Suppl video 2 from Neutrophil Conversion to a Tumor-Killing Phenotype Underpins Effective Microbial Therapy
od: Andrew O. Yam (15293045)
Izdano: (2025)

Suppl video 3 from Neutrophil Conversion to a Tumor-Killing Phenotype Underpins Effective Microbial Therapy
od: Andrew O. Yam (15293045)
Izdano: (2025)

Cannot write session to /tmp/vufind_sessions/sess_891r1sjsslbe9l768pkaopk37f